Drugdiscovery >> Clinical Trials >> News
4413
Views
SelG1 in Phase 2 Sickle Cell Pain Trial - drugdiscovery.com
SelG1 in Phase 2 Sickle Cell Pain Trial - drugdiscovery.com


Selexys Pharmaceuticals Corporation’ anti-P-selectin monoclonal antibody SelG1 is on its way to be tested in Phase 2 trial with or without hydroxyurea therapy in sickle cell disease patients with sickle cell-related pain crises. The patient enrollment has been initiated.
Read More >>


Tags: SelG1, sickle cell, disease, selexys, anti-P-selectin monoclonal antibody, antibody - August 21, 2013
Related Articles
8050
Views
Mallinckrodt's pain drug successful in Phase 3 clinical trial Mallinckrodt's pain drug successful in Phase 3 clinical trial
The experimental pain drug MNK-795 met the primary endpoint of a Phase 3 study, improving the pain scores, compared to placebo, in patients with acute pain after surgery. Read More >>

Tags: pain drug, MNK-795, clinical trial, Mallinckrodt

17764
Views
Autologous immune cell therapy tested in liver cancer patients Autologous immune cell therapy tested in liver cancer patients
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of proprietary cell therapies for certain degenerative and malignant diseases, announced positive results from its phase Read More >>

Tags: cancer stem cell, dendritic cell, immunotherapy, liver cancer, phase I trial, liver cancer, hepatocellular carcinoma, HCC, clinical trial, immune cells, therapy, dendritic cells

8154
Views
Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung
Oncolytics Biotech’s drug Reolysin, used in combination with carboplatin and paclitaxel, has shown high tumor shrinkage in patients with metastatic or recurrent squamous cell carcinoma of the lung Read More >>

Tags: Reolysin, clinical trial, squamous cell carcinoma of the lung, SCCLC, Oncolytics Biotech

7146
Views
New succes on Phase II trial of a new GBM vaccine New succes on Phase II trial of a new GBM vaccine
ImmunoCellular Therapeutics Ltd's GBM vaccine proved to be successful on Phase II clinical trial. GBM is one of the most offensive cancer of the brain. There are few therapeutic options for this, so t Read More >>

Tags: GBM, Brain Cancer, ImmunoCellular Therapeutics, Ltd, Phase II. clinical trial.

21003
Views
Lilly’s experimental lung cancer drug successful in phase III clinical trial Lilly’s experimental lung cancer drug successful in phase III clinical trial
Eli Lilly & Co. announced in a press release that necitumumab (IMC-11F8), in combination with gemcitabine and cisplatin, as first-line treatment for stage IV squamous cell non-small cell lung cancer Read More >>

Tags: Eli Lilly, necitumumab, advanced lung cancer, new drug,experimental drug, stage IV, squamous cell non-small cell lung cancer

5766
Views
Edison Pharmaceuticals announces Phase 2 trial of EPI-743 Edison Pharmaceuticals announces Phase 2 trial of EPI-743
A trial is a double-blind, placebo-controlled crossover study of EPI-743 in patients with defined or undefined genetic diagnoses that feature cellular oxidation/reduction or energy production defects. Read More >>

Tags: Edison, clinical trial, EPI-743, disorders of energy utilization, oxidation-reduction

3457
Views
New Clinical trial for curin B-cell Cancer New Clinical trial for curin B-cell Cancer
Senesco Technologies reported the treatment of the first patient at the Company’s newly opened clinical-trial site at Seattle Cancer Care Alliance (SCCA). This patient is part of Senesco’s Phase 1 Read More >>

Tags: B-cell, research, cancer

2943
Views
Interferon-free hepatitis coctail of AbbVie enters Phase III Interferon-free hepatitis coctail of AbbVie enters Phase III
The new drug of AbbVie has entered clinical trial phase II. It cures hepatitis C, and provides a ribavirin-free, all-oral treatment without interferon. Read More >>

Tags: interferon, hepatitis C, clinical trial, Phase III

3316
Views
The biggest heart-trial takes place The biggest heart-trial takes place
The biggest heart-related clinical trial is going to take place in London. Stem cell technology is going to be tested on patient, some of whom has already gone through heart-attack. Read More >>

Tags: heart attack, stem cell, clinical trial

3441
Views
Phase-III trial of new sarcoma drug Phase-III trial of new sarcoma drug
620 patients were enrolled to the Phase-III trial of TH-302. The trial is led by Threshold Pharmaceuticals. The new drug might open a new chapter in the history of advanced soft-tissue sarcoma. Read More >>

Tags: soft tissue sarcoma, phase-III trial, soft tissue

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013